Covid-19 Workshop
Topics
Meeting category
Date(s)
16 Nov 2021
Meeting type
Virtual Meeting
Organizer

COVID-19 Clinical Management Workshop 2021

Related Enduring Materials

Enduring Materials

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Session 1: Keynote Talk - 18:10
18:10 CET
COVID-19 Therapeutics: State-Of-The-Art
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
Session 2: Diagnostic Challenges - 18:30
18:30 CET
SARS-CoV-2 Variants and Disease Severity
Robert Shafer, MD
Stanford University, United States
18:45 CET
Sorting Out Respiratory Illnesses
Sanjat Kanjilal, MD, MPH
Brigham & Women’s Hospital, Harvard Medical School & Harvard Pilgrim Healthcare Institute, United States
Session 3: COVID-19 Therapeutics: Present and Future - 19:30
19:30 CET
Small Molecules in the Pipeline
Johan Neyts, PhD
Rega Institute for Medical Research, Belgium
19:45 CET
Monoclonal Antibodies for SARS-CoV-2
Katharine Bar, MD
Perelman School of Medicine, University of Pennsylvania, United States
20:00 CET
Immunomodulating Therapies
Karine Lacombe, MD, PhD
Hôpital Saint Antoine Paris, France
Session 4: Clinical Management - 20:35
20:35 CET
Complications of Acute COVID-19
Otavio Berwanger, MD, PhD
Academic Research Organization, Hospital Israelita Albert Einstein, Brazil
20:50 CET
Long COVID (Post-Acute COVID-19 Syndrome)
Susan Swindells, MBBS
University of Nebraska Medical Center, United States
21:05 CET
Pediatric Manifestations of COVID-19
Jeffrey Vergales, MD, MS
University of Virginia Medical Center, United States
21:20 CET
Respiratory Management of COVID-19
Vikram Mukherjee, MD, FRCP(Edin)
Bellevue Hospital, United States
Overview
Welcome

COVID-19 Clinical Management Workshop was held virtually on 16 November 2021.

This workshop aims to increase knowledge and facilitate discussion on the many remaining unknowns that healthcare professionals encounter on a daily basis when caring for people with COVID-19.

Our goal is to address the many aspects of COVID-19 including pathogenesis, epidemiology, therapeutics for prevention and treatment, and clinical management in both the outpatient as well as inpatient settings.

This global program hopes to promote understanding and stimulate further discussion and research among infection diseases specialists, pulmonologists, intensivists, epidemiologists, and community scientists.

This is done in the truly global context of the COVID-19 pandemic, considering regional differences in access to medications, health system capacity, and public measures. 

The Organizing Committee

Who Should Attend?
• Infectious disease clinicians (including clinical virologists), primary care physicians, intensivists, microbiologists, pulmonologists, epidemiologists, specialized nurses;

• Public health officials;

• Researchers; and

• Community.
Learning Objectives
After the program the participants will be able to:

• Describe the key elements of the clinical management of COVID-19;

• Identify diagnostic challenges and the clinical manifestations of COVID-19; and

• Define the therapeutic options available and those in advanced clinical trials.
Meeting Objectives
This workshop aims to:

• Provide a platform for presentation and discussion of the latest scientific developments on the clinical management of COVID-19;

• Gather experts from different disciplines involved in the clinical management of COVID-19; and

• Educate health care professionals on the current and upcoming challenges in the clinical management of COVID-19.
Committees
Organizing Committee
Support

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in COVID-19.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Dr. Giorgio Karapetsas at giorgio.karapetsas@amededu.com or call +31 30 230 7140.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Digital and printed advertising opportunities 
  • Social media shout-outs


 
*Subject to the support level.

Endorsers
The COVID-19 Clinical Management Workshop is endorsed by the following organization: